Consistent with persister enrichment in ICB treated tumors, ATF3 and IDO1 are induced in 4MOSC159 orthotopic syngeneic mouse head and neck squamous cell carcinoma tumors which have regressed during anti-PD-1 treatment (Figures 3G–H and S5A). This evidence concerns the gene ATF3 and head and neck squamous cell carcinoma.